Show simple item record

dc.contributor.authorLesicka, Monika
dc.contributor.authorJabłońska, Ewa
dc.contributor.authorWieczorek, Edyta
dc.contributor.authorSeroczyńska, Barbara
dc.contributor.authorSiekierzycka, Anna
dc.contributor.authorSkokowski, Jarosław
dc.contributor.authorKalinowski, Leszek
dc.contributor.authorWąsowicz, Wojciech
dc.contributor.authorReszka, Edyta
dc.date.accessioned2018-12-03T09:23:49Z
dc.date.available2018-12-03T09:23:49Z
dc.date.issued2018
dc.identifier.citationPLoS ONE 2018, 13 (6):e0199622en
dc.identifier.issn1932-6203
dc.identifier.pmid29958276
dc.identifier.doi10.1371/journal.pone.0199622
dc.identifier.urihttp://hdl.handle.net/10146/618213
dc.description.abstractBreast cancer has a multifactorial etiology. One of the supposed and novel mechanisms is an alteration of circadian gene expression. Circadian genes play a crucial role in many physiological processes. These processes, such as genomic stability, DNA repair mechanism and apoptosis, are frequently disrupted in breast tumors. To assess the significance of circadian gene expression in breast cancer, we carried out an analysis of CLOCK, BMAL1, NPAS2, PER1, PER2, PER3 and CRY1, CRY2, TIMELESS, CSNK1E expression by the use of the quantitative Real-Time PCR technique in tumor tissue and non-tumor adjacent normal tissue sampled from 107 women with a newly diagnosed disease. The obtained data were compared to the clinical and histopathological features. PER1, PER2, PER3, CRY2 were found to be significantly down-expressed, while CLOCK, TIMELESS were over-expressed in the studied tumor samples compared to the non-tumor samples. Only gene expression of CRY1 was significantly down-regulated with progression according to the TNM classification. We found significantly decreased expression of CRY2, PER1, PER2 genes in the ER/PR negative breast tumors compared to the ER/PR positive tumors. Additionally, expression of CRY2, NPAS2 genes had a decreased level in the poorly differentiated tumors in comparison with the well and moderately differentiated ones. Our results indicate that circadian gene expression is altered in breast cancer tissue, which confirms previous observations from various animal and in vitro studies.
dc.description.sponsorshipThis work was supported by the National Science Center (Grant No. 2014/15/N/NZ5/01671) (to ML), https://www.ncn.gov.pl/?language=en, and partially supported by Ministry of Science and Higher Education Poland DIR/WK/2017/01 (to LK), http://www.nauka.gov.pl/en/, and Internal grant for statutory activity at Nofer Institute of Occupational Medicine IMP 14.4/2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.en
dc.language.isoenen
dc.relation.urlhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0199622en
dc.rightsArchived with thanks to PloS oneen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectcircadianen
dc.subjectbreast canceren
dc.titleAltered circadian genes expression in breast cancer tissue according to the clinical characteristicsen
dc.typeArticleen
dc.contributor.departmentNofer Institute of Occupational Medicineen
dc.identifier.journalPloS oneen
refterms.dateFOA2018-12-17T18:10:13Z
html.description.abstractBreast cancer has a multifactorial etiology. One of the supposed and novel mechanisms is an alteration of circadian gene expression. Circadian genes play a crucial role in many physiological processes. These processes, such as genomic stability, DNA repair mechanism and apoptosis, are frequently disrupted in breast tumors. To assess the significance of circadian gene expression in breast cancer, we carried out an analysis of CLOCK, BMAL1, NPAS2, PER1, PER2, PER3 and CRY1, CRY2, TIMELESS, CSNK1E expression by the use of the quantitative Real-Time PCR technique in tumor tissue and non-tumor adjacent normal tissue sampled from 107 women with a newly diagnosed disease. The obtained data were compared to the clinical and histopathological features. PER1, PER2, PER3, CRY2 were found to be significantly down-expressed, while CLOCK, TIMELESS were over-expressed in the studied tumor samples compared to the non-tumor samples. Only gene expression of CRY1 was significantly down-regulated with progression according to the TNM classification. We found significantly decreased expression of CRY2, PER1, PER2 genes in the ER/PR negative breast tumors compared to the ER/PR positive tumors. Additionally, expression of CRY2, NPAS2 genes had a decreased level in the poorly differentiated tumors in comparison with the well and moderately differentiated ones. Our results indicate that circadian gene expression is altered in breast cancer tissue, which confirms previous observations from various animal and in vitro studies.


Files in this item

Thumbnail
Name:
Altered cicardian genes.pdf
Size:
2.001Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Archived with thanks to PloS one
Except where otherwise noted, this item's license is described as Archived with thanks to PloS one